What is Regenxbio's net income?

Regenxbio (RGNX) reported net income of -$90.05M in Q1 2026.

How has Regenxbio's net income changed year-over-year?

Regenxbio's net income decreased by 1580.4% year-over-year, from $6.08M to -$90.05M.

What is the long-term trend for Regenxbio's net income?

Over 4 years (2021 to 2025), Regenxbio's net income has grown at a 11.0% compound annual growth rate (CAGR), from $127.84M to -$193.88M.

What does net income mean?

The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Regenxbio RGNX Net Income

Net Income at other companies

Regeneron PharmaceuticalsREGN

$727.2M-10.1%

Sarepta Therapeutics, Inc.SRPT

$330.96M+174%

BiogenBIIB

$319.5M+32.8%

BioMarin PharmaceuticalsBMRN

$105.53M-43.2%

EyePoint, Inc. EYPT

-$84.83M-87.7%

Ultragenyx PharmaceuticalRARE

-$185M-22.5%

Other financials

Income statement

See full

Revenue$6.4M-92.8%

Gross profit$14.9M+35.7%

Operating income-$83.4M-787%

EPS (diluted)-$1.72-1,533%

Balance sheet

See full

Cash & equivalents$15.2M-88.3%

Total debt$71.1M-11.0%

Total equity$21.1M-92.3%

Total assets$341.9M-30.4%

Cash flow

See full

Operating cash flow-$76.2M-327%

CapEx$1.2M+20.6%

Free cash flow-$77.4M-337%

Valuation

See full

Market cap$529.38M+24.6%

Enterprise value$585.22M+56.3%

P/S6×+3.3×

Profitability

See full

Gross margin59.7%+1.0pp

Operating margin-292.3%-613pp

Net margin-330.2%-588pp

FCF margin-269.2%-364pp

Returns & leverage

See full

Return on equity-196.4%-288pp

Debt / equity3.4×+3.1×

Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regenxbio's net income?: Regenxbio (RGNX) reported net income of -$90.05M in Q1 2026.
How has Regenxbio's net income changed year-over-year?: Regenxbio's net income decreased by 1580.4% year-over-year, from $6.08M to -$90.05M.
What is the long-term trend for Regenxbio's net income?: Over 4 years (2021 to 2025), Regenxbio's net income has grown at a 11.0% compound annual growth rate (CAGR), from $127.84M to -$193.88M.
What does net income mean?: The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.